Skip to main content
Download PDF
- Main
Ablating N‐acetylaspartate prevents leukodystrophy in a Canavan disease model
- Guo, Fuzheng;
- Bannerman, Peter;
- Ko, Emily Mills;
- Miers, Laird;
- Xu, Jie;
- Burns, Travis;
- Li, Shuo;
- Freeman, Ernest;
- McDonough, Jennifer A;
- Pleasure, David
Published Web Location
https://doi.org/10.1002/ana.24392Abstract
Canavan disease is caused by inactivating ASPA (aspartoacylase) mutations that prevent cleavage of N-acetyl-L-aspartate (NAA), resulting in marked elevations in central nervous system (CNS) NAA and progressively worsening leukodystrophy. We now report that ablating NAA synthesis by constitutive genetic disruption of Nat8l (N-acetyltransferase-8 like) permits normal CNS myelination and prevents leukodystrophy in a murine Canavan disease model.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.